Please assess the completion status of the following clinical trial:

Trial Title: Iron Supplementation of Marginally Low Birth Weight Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Marginally low birth weight (2000-2500 g)~* Healthy at inclusion(6 weeks of age)~* No previous blood transfusion~* No previous iron supplementation~Exclusion Criteria:~* Anemia at inclusion

- Gender: ALL
- Minimum Age: 39 Days
- Maximum Age: 45 Days
- Healthy Volunteers: t

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): Placebo
- 2 (Type: EXPERIMENTAL): 1 mg/kg/day from age 6 weeks to 6 months
- 3 (Type: EXPERIMENTAL): 2 mg/kg/day from age 6 weeks to 6 months

Based on this trial design, predict the completion outcome and termination type (if applicable).